These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7689509)

  • 1. The clinical significance of reactivity to individual epitopes of the hepatitis C viral genome.
    Yatsuhashi H; Inokuchi K; Inoue O; Matsumura N; Koga M; Kosakai Y; Yano M
    Gastroenterol Jpn; 1993 May; 28 Suppl 5():6-11. PubMed ID: 7689509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnosis of hepatitis C and its future].
    Yano M
    Rinsho Byori; 1992 Sep; 40(9):935-40. PubMed ID: 1279248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced sensitivity of a second generation ELISA for antibody to hepatitis C virus.
    Bresters D; Cuypers HT; Reesink HW; Schaasberg WP; van der Poel CL; Mauser-Bunschoten EP; Houghton M; Choo QL; Kuo G; Lesniewski R
    Vox Sang; 1992; 62(4):213-7. PubMed ID: 1379394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of hepatitis C virus markers in patients with NANB hepatitis.
    Yatsuhashi H; Inoue O; Koga M; Nagataki S; Mizuno K; Kolberg J; Beall E; Cha TA; Irvine B; Kuo G
    J Virol Methods; 1992 Apr; 37(1):13-21. PubMed ID: 1374072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum hepatitis C virus (HCV)-RNA and response to alpha-interferon in anti-HCV positive chronic hepatitis.
    Magrin S; Craxì A; Fabiano C; Fiorentino G; Marino L; Almasio P; Pinzello GB; Palazzo U; Vitale M; Maggio A
    J Med Virol; 1992 Nov; 38(3):200-6. PubMed ID: 1283753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved diagnosis of chronic hepatitis C virus infection by detection of antibody to multiple epitopes: confirmation by antibody to synthetic oligopeptides.
    Brown D; Powell L; Morris A; Rassam S; Sherlock S; McIntyre N; Zuckerman AJ; Dusheiko GM
    J Med Virol; 1992 Nov; 38(3):167-71. PubMed ID: 1283751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to hepatitis C virus and hepatitis C virus infection.
    Yuki N; Hayashi N; Kasahara A; Hagiwara H; Fusamoto H; Kamada T
    Gastroenterol Jpn; 1993 May; 28 Suppl 5():76-9. PubMed ID: 7689512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of highly positive c22-3 "indeterminate" second-generation hepatitis C virus (HCV) recombinant immunoblot assay (RIBA) and resolution by third-generation HCV RIBA.
    Pawlotsky JM; Fleury A; Choukroun V; Deforges L; Roudot-Thoraval F; Aumont P; Duval J; Dhumeaux D
    J Clin Microbiol; 1994 May; 32(5):1357-9. PubMed ID: 7519631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity of an anti-HCV core peptide ELISA.
    Bresters D; Reesink HW; Cuypers HT; Jansen PL; Mauser-Bunschoten EP; van der Poel CL; Lelie PN
    J Med Virol; 1992 Jul; 37(3):187-91. PubMed ID: 1279109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation between reactivity to the NS-4 region peptides of hepatitis C virus (HCV) and clinical features among patients infected with HCV genotype 1b.
    Sakugawa H; Nakasone H; Nakayoshi T; Kawakami Y; Kinjo F; Saito A; Nakayoshi T; Yamashiro A
    Microbiol Immunol; 1998; 42(4):299-303. PubMed ID: 9623917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotype dependence of hepatitis C virus antibodies detectable by the first-generation enzyme-linked immunosorbent assay with C100-3 protein.
    Nagayama R; Tsuda F; Okamoto H; Wang Y; Mitsui T; Tanaka T; Miyakawa Y; Mayumi M
    J Clin Invest; 1993 Sep; 92(3):1529-33. PubMed ID: 7690782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-c100 antibodies to hepatitis C virus in patients with chronic hepatitis C virus infection treated with interferon.
    Nakano Y; Kiyosawa K; Sodeyama T; Tanaka E; Yoshizawa K; Furuta K; Nakatsuji Y; Urushihara A; Furuta S
    Scand J Gastroenterol; 1993 Apr; 28(4):335-42. PubMed ID: 8387696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Second generation hepatitis-C virus test and polymerase chain reaction in anti-C 100 negative patients with chronic non-A, non-B hepatitis].
    Zala G; Havelka J; Wicki AN; Joller-Jemelka HI; Meier B; Schmid M; Bühler H
    Schweiz Med Wochenschr; 1992 Mar; 122(11):363-8. PubMed ID: 1313601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus detection is facilitated by the combined use of c100 protein and GOR epitope.
    Hayashi J; Nakashima K; Hirata M; Noguchi A; Akazawa K; Maeda Y; Kashiwagi S
    Gastroenterol Jpn; 1992 Oct; 27(5):632-7. PubMed ID: 1385249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pattern of 5-1-1 and c100-3 only on hepatitis C virus (HCV) recombinant immunoblot assay does not reflect HCV infection in blood donors.
    Busch MP; Tobler L; Quan S; Wilber JC; Johnson P; Polito A; Steane E; Zola A; Bahl C; Nelles M
    Transfusion; 1993 Jan; 33(1):84-8. PubMed ID: 7678710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isotype-specific immune response to a single hepatitis C virus core epitope defined by a human monoclonal antibody: diagnostic value and correlation to PCR.
    Siemoneit K; da Silva Cardoso M; Wölpl A; Epple S; Wintersinger H; Koerner K; Kubanek B
    Ann Hematol; 1994 Sep; 69(3):129-33. PubMed ID: 8086507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of hepatitis C virus infection among long-term hemodialysis patients: detection of hepatitis C virus RNA in plasma.
    Sakamoto N; Enomoto N; Marumo F; Sato C
    J Med Virol; 1993 Jan; 39(1):11-5. PubMed ID: 7678636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to recombinant and synthetic peptides derived from the hepatitis C virus genome in long-term-studied patients with posttransfusion hepatitis C.
    Mattsson L; Gutierrez RA; Dawson GJ; Lesniewski RR; Mushahwar LK; Weiland O
    Scand J Gastroenterol; 1991 Dec; 26(12):1257-62. PubMed ID: 1722348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serodiagnosis of hepatitis C by a recombinant hepatitis C virus protein].
    Hayashi N; Yuki N; Kasahara A; Fusamoto H; Kamada T
    Nihon Rinsho; 1993 Feb; 51(2):329-33. PubMed ID: 7681883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation of the antibody against core protein of hepatitis C virus.
    Ohkoshi S; Watanabe M; Kuwana K; Tawaraya H; Kamimura T; Asakura H
    Gastroenterol Jpn; 1993 May; 28 Suppl 5():80-3. PubMed ID: 7689513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.